Learn how Genentech is Automating Drug Research with Amazon Bedrock Agents | Amazon Web Services

Опубликовано 18 декабря 2024, 20:34

Learn how Genentech uses AWS Bedrock Agents to improve their drug research process, reducing manual work in biomarker validation. The solution automates about 43,200 hours (nearly 5 years) of work across different therapeutic areas which helps Genentech is speed up drug target identification and improve research efficiency, which may lead to faster drug development.

To learn more check out:
go.aws/3vC9RV8
go.aws/427KTcy

Subscribe to AWS: go.aws/subscribe

Sign up for AWS: go.aws/signup
AWS free tier: go.aws/free
Explore more: go.aws/more
Contact AWS: go.aws/contact

Next steps:
Explore on AWS in Analyst Research: go.aws/reports
Discover, deploy, and manage software that runs on AWS: go.aws/marketplace
Join the AWS Partner Network: go.aws/partners
Learn more on how Amazon builds and operates software: go.aws/library

Do you have technical AWS questions?
Ask the community of experts on AWS re:Post: go.aws/3lPaoPb

Why AWS?
Amazon Web Services (AWS) is the world’s most comprehensive and broadly adopted cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—use AWS to be more agile, lower costs, and innovate faster.

#GenentechInnovation #AmazonBedrock #GenAIAgents #DrugDevelopment #AWSforLifeSciences #AWS #AmazonWebServices #CloudComputing